Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. (Q33517463)

27 July 2017

1 reference

title

Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. (English)

1 reference

27 July 2017

0 references

Yoichi Moroi

1

1 reference

27 July 2017

5 December 2009

1 reference

International Journal of Clinical Oncology

27 July 2017

1 reference

27 July 2017

14

1 reference

27 July 2017

6

1 reference

27 July 2017

485-489

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-009-0942-z

27 July 2017

0 references

cites work

Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma

1 reference

12 December 2020

The Sydney Melanoma Unit experience of sentinel lymphadenectomy for melanoma

1 reference

12 December 2020

Importance of sentinel lymph node biopsy in patients with thin melanoma

1 reference

12 December 2020

Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis

1 reference

12 December 2020

Why perform sentinel-lymph-node biopsy in patients with melanoma?

1 reference

12 December 2020

Comparison of three micromorphometric pathology classifications of melanoma metastases in the sentinel node

1 reference

12 December 2020

Sentinel-node biopsy or nodal observation in melanoma

1 reference

12 December 2020

Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma

1 reference

12 December 2020

A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma.Preliminary results

1 reference

12 December 2020

Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection

1 reference

12 December 2020

The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

1 reference

12 December 2020

Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme.

1 reference

12 December 2020

Technical details of intraoperative lymphatic mapping for early stage melanoma

1 reference

12 December 2020

Complications associated with sentinel lymph node biopsy for melanoma.

1 reference

12 December 2020

The role of sentinel lymph node biopsy in the management of melanoma

1 reference

12 December 2020

Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse

1 reference

12 December 2020

Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma

1 reference

12 December 2020

Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.

1 reference

12 December 2020

Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience.

1 reference

12 December 2020

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial

1 reference

12 December 2020

Inefficacy of immediate node dissection in stage 1 melanoma of the limbs

1 reference

12 December 2020

The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer

1 reference

12 December 2020

A new American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

12 December 2020

The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.

1 reference

12 December 2020

Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases

1 reference

12 December 2020

Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.

1 reference

12 December 2020

Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes

1 reference

12 December 2020

EANM-EORTC general recommendations for sentinel node diagnostics in melanoma

1 reference

12 December 2020

Prognostic false-positivity of the sentinel node in melanoma

1 reference

12 December 2020

The amount of metastatic melanoma in a sentinel lymph node: does it have prognostic significance?

1 reference

12 December 2020

Positive nonsentinel node status predicts mortality in patients with cutaneous melanoma

1 reference

12 December 2020

Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients

1 reference

12 December 2020

Molecular staging of malignant melanoma: correlation with clinical outcome

1 reference

12 December 2020

Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients

1 reference

12 December 2020

10.1007/S10147-009-0942-Z

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

19967482